Inborn errors of the development of human natural killer cells

Current Opinion in Allergy and Clinical Immunology

Volumn 13, Issue 6, 2013, Pages 589-595

  Jouanguy, Emmanuelle ^a,b,c   Gineau, Laure ^a,b   Cottineau, Julien ^a,b   Béziat, Vivien ^d   Vivier, Eric ^e,f,g,h   Casanova, Jean Laurent ^a,b,c  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c ROCKEFELLER UNIVERSITY   (United States)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^f CNRS   (France)

^g AIX MARSEILLE UNIVERSITY   (France)

^h HÔPITAL DE LA CONCEPTION   (France)

Author keywords

Genetic diseases; Immunodeficiencies; Natural killer cells

Indexed keywords

ADENOSINE DEAMINASE; ADENYLATE KINASE; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR GAMMA; JANUS KINASE 3; STAT5B PROTEIN; TRANSCRIPTION FACTOR GATA 2;

CELL DIFFERENTIATION; CELL FUNCTION; CELL ISOLATION; CELL MATURATION; GENE; HEMATOPOIESIS; HUMAN; INBORN ERROR OF METABOLISM; JAK3 DEFICIENCY; NATURAL KILLER CELL; PRIORITY JOURNAL; REVIEW; SEVERE COMBINED IMMUNODEFICIENCY; SIGNAL TRANSDUCTION;

ADENOSINE DEAMINASE; ADENYLATE KINASE; AGAMMAGLOBULINEMIA; GATA2 TRANSCRIPTION FACTOR; HUMANS; JANUS KINASE 2; JANUS KINASE 3; KILLER CELLS, NATURAL; MINICHROMOSOME MAINTENANCE COMPLEX COMPONENT 4; MYCOBACTERIUM INFECTIONS; SEVERE COMBINED IMMUNODEFICIENCY; VIRUS DISEASES;

EID: 84889888096     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0000000000000011     Document Type: Review

References (87)

1. Spits H, Artis D, Colonna M, et al. Innate lymphoid cells: A proposal for uniform nomenclature. Nat Rev Immunol 2013; 13:145-149.
2. Yokoyama WM. Natural killer cell receptors. Curr Opin Immunol 1998; 10:298-305.
3. Lanier LL. Natural killer cell receptor signaling. Curr Opin Immunol 2003; 15:308-314.
4. Moffett-King A. Natural killer cells and pregnancy. Nat Rev Immunol 2002; 2:656-663.
5. Long EO, Sik Kim H, Liu D, et al. Controlling natural killer cell responses: integration of signals for activation and inhibition. Annu Rev Immunol 2013; 31:227-258.
6. Kim S, Poursine-Laurent J, Truscott SM, et al. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 2005; 436:709-713.
7. Narni-Mancinelli E, Ugolini S, Vivier E. Tuning the threshold of natural killer cell responses. Curr Opin Immunol 2013; 25:53-58. A clear and comprehensive review on the regulatory role of the NK cells on the immune response in mice.
8. Hesslein DG, Lanier LL. Transcriptional control of natural killer cell development and function. Adv Immunol 2011; 109:45-85. A clear and comprehensive review on the transcription factors involved in the NK cell development and function.
9. Narni-Mancinelli E, Chaix J, Fenis A, et al. Fate mapping analysis of lymphoid cells expressing the NKp46 cell surface receptor. Proc Natl Acad Sci U S A 2011; 108:18324-18329.
10. Di Santo JP. Natural killer cell developmental pathways: A question of balance. Annu Rev Immunol 2006; 24:257-286.
11. Soderquest K, Powell N, Luci C, et al. Monocytes control natural killer cell differentiation to effector phenotypes. Blood 2011; 117:4511-4518.
12. Jaeger BN, Donadieu J, Cognet C, et al. Neutrophil depletion impairs natural killer cell maturation, function, and homeostasis. J Exp Med 2012; 209:565-580. The authors show that neutrophils are required for the NK cell maturation and education in humans and mice.
13. Arase H, Mocarski ES, Campbell AE, et al. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 2002; 296:1323-1326.
14. Brown MG, Dokun AO, Heusel JW, et al. Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science 2001; 292: 934-937.
15. Lee SH, Girard S, Macina D, et al. Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily. Nat Genet 2001; 28:42-45.
16. Min-Oo G, Kamimura Y, Hendricks DW, et al. Natural killer cells: walking three paths down memory lane. Trends Immunol 2013; 34:251-258.
17. Moretta A, Marcenaro E, Parolini S, et al. NK cells at the interface between innate and adaptive immunity. Cell Death Differ 2008; 15:226-233.
18. Vivier E, Raulet DH, Moretta A, et al. Innate or adaptive immunity? The example of natural killer cells. Science 2011; 331:44-49.
19. Jost S, Altfeld M. Control of human viral infections by natural killer cells. Annu Rev Immunol 2013; 31:163-194. A clear review on the function of NK cells in the antiviral immunity in mice.
20. Narni-Mancinelli E, Jaeger BN, Bernat C, et al. Tuning of natural killer cell reactivity by NKp46 and Helios calibrates T cell responses. Science 2012; 335:344-348.
21. Walzer T, Dalod M, Robbins SH, et al. Natural-killer cells and dendritic cells: 'l'union fait la force'. Blood 2005; 106:2252-2258.
22. Bé ziat V, Descours B, Parizot C, et al. NK cell terminal differentiation: correlated stepwise decrease of NKG2A and acquisition of KIRs. PLoS One 2010; 5:e11966.
23. Bjorkstrom NK, Riese P, Heuts F, et al. Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education. Blood 2010; 116:3853-3864.
24. Freud AG, Caligiuri MA. Human natural killer cell development. Immunol Rev 2006; 214:56-72.
25. Juelke K, Killig M, Luetke-Eversloh M, et al. CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells. Blood 2010; 116:1299-1307.
26. Orange JS. Human natural killer cell deficiencies and susceptibility to infection. Microbes Infect 2002; 4:1545-1558.
27. Orange JS. Human natural killer cell deficiencies. Curr Opin Allergy Clin Immunol 2006; 6:399-409.
28. Orange JS, Ballas ZK. Natural killer cells in human health and disease. Clin Immunol 2006; 118:1-10.
29. Bigley V, Haniffa M, Doulatov S, et al. The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency. J Exp Med 2011; 208:227-234.
30. Calvo KR, Vinh DC, Maric I, et al. Myelodysplasia in autosomal dominant and sporadic monocytopenia immunodeficiency syndrome: diagnostic features and clinical implications. Haematologica 2011; 96:1221-1225.
31. Eidenschenk C, Dunne J, Jouanguy E, et al. A novel primary immunodeficiency with specific natural-killer cell deficiency maps to the centromeric region of chromosome 8. Am J Hum Genet 2006; 78:721-727.
32. Eidenschenk C, Jouanguy E, Alcais A, et al. Familial NK cell deficiency associated with impaired IL-2-and IL-15-dependent survival of lymphocytes. J Immunol 2006; 177:8835-8843.
33. Etzioni A, Eidenschenk C, Katz R, et al. Fatal varicella associated with selective natural killer cell deficiency. J Pediatr 2005; 146:423-425.
34. Notarangelo LD, Mazzolari E. Natural killer cell deficiencies and severe varicella infection. J Pediatr 2006; 148:563-564. [author reply 4]
35. Shaw RK, Issekutz AC, Fraser R, et al. Bilateral adrenal EBV-associated smooth muscle tumors in a child with a natural killer cell deficiency. Blood 2012; 119:4009-4012.
36. Blackburn MR, Kellems RE. Adenosine deaminase deficiency: metabolic basis of immune deficiency and pulmonary inflammation. Adv Immunol 2005; 86:1-41.
37. Lee HJ, Pyo JO, Oh Y, et al. AK2 activates a novel apoptotic pathway through formation of a complex with FADD and caspase-10. Nat Cell Biol 2007; 9:1303-1310.
38. Hirschhorn R, Roegner V, Rubinstein A, Papageorgiou P. Plasma deoxyadenosine, adenosine, and erythrocyte deoxyATP are elevated at birth in an adenosine deaminase-deficient child. J Clin Invest 1980; 65:768-771.
39. Lagresle-Peyrou C, Six EM, Picard C, et al. Human adenylate kinase 2 deficiency causes a profound hematopoietic defect associated with sensorineural deafness. Nat Genet 2009; 41:106-111.
40. Heltzer ML, Paessler M, Raffini L, et al. Successful haploidentical bone marrow transplantation in a patient with reticular dysgenesis: three-year follow-up. J Allergy Clin Immunol 2007; 120:950-952.
41. Pannicke U, Honig M, Hess I, et al. Reticular dysgenesis (aleukocytosis) is caused by mutations in the gene encoding mitochondrial adenylate kinase 2. Nat Genet 2009; 41:101-105.
42. Thompson LF, Van de Wiele CJ, Laurent AB, et al. Metabolites from apoptotic thymocytes inhibit thymopoiesis in adenosine deaminase-deficient fetal thymic organ cultures. J Clin Invest 2000; 106:1149-1157.
43. Apasov SG, Blackburn MR, Kellems RE, et al. Adenosine deaminase deficiency increases thymic apoptosis and causes defective T cell receptor signaling. J Clin Invest 2001; 108:131-141.
44. Aldrich MB, Chen W, Blackburn MR, et al. Impaired germinal center maturation in adenosine deaminase deficiency. J Immunol 2003; 171: 5562-5570.
45. Freud AG, Yokohama A, Becknell B, et al. Evidence for discrete stages of human natural killer cell differentiation in vivo. J Exp Med 2006; 203:1033-1043.
46. Ficara F, Superchi DB, Hernandez RJ, et al. IL-3 or IL-7 increases ex vivo gene transfer efficiency in ADA-SCID BM CD34 ; cells while maintaining in vivo lymphoid potential. Mol Ther 2004; 10:1096-1108.
47. Noguchi M, Yi H, Rosenblatt HM, et al. Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 1993; 73:147-157.
48. Buckley RH, Schiff RI, Schiff SE, et al. Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants. J Pediatr 1997; 130:378-387.
49. Stephan JL, Vlekova V, Le Deist F, et al. Severe combined immunodeficiency: A retrospective single-center study of clinical presentation and outcome in 117 patients. J Pediatr 1993; 123:564-572.
50. Macchi P, Villa A, Giliani S, et al. Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature 1995; 377:65-68.
51. Nadeau K, Hwa V, Rosenfeld RG. STAT5b deficiency: An unsuspected cause of growth failure, immunodeficiency, and severe pulmonary disease. J Pediatr 2011; 158:701-708.
52. Bernasconi A, Marino R, Ribas A, et al. Characterization of immunodeficiency in a patient with growth hormone insensitivity secondary to a novel STAT5b gene mutation. Pediatrics 2006; 118:e1584-e1592.
53. Scaglia PA, Martinez AS, Feigerlova E, et al. A novel missense mutation in the SH2 domain of the STAT5B gene results in a transcriptionally inactive STAT5b associated with severe IGF-I deficiency, immune dysfunction, and lack of pulmonary disease. J Clin Endocrinol Metab 2012; 97:E830-E839.
54. Vidarsdottir S, Walenkamp MJ, Pereira AM, et al. Clinical and biochemical characteristics of a male patient with a novel homozygous STAT5b mutation. J Clin Endocrinol Metab 2006; 91:3482-3485.
55. Kofoed EM, Hwa V, Little B, et al. Growth hormone insensitivity associated with a STAT5b mutation. N Engl J Med 2003; 349:1139-1147.
56. Dickinson RE, Griffin H, Bigley V, et al. Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency. Blood 2011; 118:2656-2658.
57. Hsu AP, Sampaio EP, Khan J, et al. Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood 2011; 118:2653-2655.
58. Bigley V, Collin M. Dendritic cell, monocyte, B and NK lymphoid deficiency defines the lost lineages of a new GATA-2 dependent myelodysplastic syndrome. Haematologica 2011; 96:1081-1083.
59. Camargo JF, Lobo SA, Hsu AP, et al. MonoMAC syndrome in a patient with a GATA2 mutation: case report and review of the literature. Clin Infect Dis 2013; 57:697-699.
60. Kazenwadel J, Secker GA, Liu YJ, et al. Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature. Blood 2012; 119:1283-1291.
61. Biron CA, Byron KS, Sullivan JL. Severe herpesvirus infections in an adolescent without natural killer cells. N Engl J Med 1989; 320:1731-1735.
62. Mace EM, Hsu AP, Monaco-Shawver L, et al. Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56(bright) subset. Blood 2013; 121:2669-2677. The authors report that GATA2 deficiency is associated with the specific lack of NK CD56bright subset and an impaired function of the NK CD56dim population.
63. Gineau L, Cognet C, Kara N, et al. Partial MCM4 deficiency in patients with growth retardation, adrenal insufficiency, and natural killer cell deficiency. J Clin Invest 2012; 122:821-832.The authors describe the first genetic cause associated with isolated NKD, partial autosomal recessive MCM4 deficiency. The mutation leads to the lack of prevention of re-replication and genomic instability. The NKD is characterized by a strong decrease of NK CD56dim subset, but a normal count of NK CD56bright subset but with a decreased proliferation ability.
64. Hughes CR, Guasti L, Meimaridou E, et al. MCM4 mutation causes adrenal failure, short stature, and natural killer cell deficiency in humans. J Clin Invest 2012; 122:814-820.
65. Russell SM, Johnston JA, Noguchi M, et al. Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID. Science 1994; 266:1042-1045.
66. Russell SM, Tayebi N, Nakajima H, et al. Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science 1995; 270:797-800.
67. Puel A, Ziegler SF, Buckley RH, Leonard WJ. Defective IL7R expression in T(-)B( ;)NK( ;) severe combined immunodeficiency. Nat Genet 1998; 20:394-397.
68. Sharfe N, Dadi HK, Shahar M, Roifman CM. Human immune disorder arising from mutation of the alpha chain of the interleukin-2 receptor. Proc Natl Acad Sci U S A 1997; 94:3168-3171.
69. Kotlarz D, Zietara N, Uzel G, et al. Loss-of-function mutations in the IL-21 receptor gene cause a primary immunodeficiency syndrome. J ExpMed 2013; 210:433-443.
70. Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, et al. Role of interleukin-2 (IL-2), IL-7, and IL-15 in natural killer cell differentiation from cord blood hematopoietic progenitor cells and fromgamma c transduced severe combined immunodeficiency X1 bone marrow cells. Blood 1996; 88:3901-3909.
71. Leclercq G, Debacker V, de Smedt M, Plum J. Differential effects of interleukin-15 and interleukin-2 on differentiation of bipotential T/natural killer progenitor cells. J Exp Med 1996; 184:325-336.
72. Ginn SL, Smyth C, Wong M, et al. A novel splice-site mutation in the common gamma chain (gammac) gene IL2RG results in X-linked severe combined immunodeficiency with an atypical NK ; phenotype. Hum Mutat 2004; 23:522-523.
73. Kumaki S, Ishii N, Minegishi M, et al. Functional role of interleukin-4 (IL-4) and IL-7 in the development of X-linked severe combined immunodeficiency. Blood 1999; 93:607-612.
74. Lin JX, Leonard WJ. The role of Stat5a and Stat5b in signaling by IL-2 family cytokines. Oncogene 2000; 19:2566-2576.
75. Behbod F, Nagy ZS, Stepkowski SM, et al. Specific inhibition of Stat5a/b promotes apoptosis of IL-2-responsive primary and tumor-derived lymphoid cells. J Immunol 2003; 171:3919-3927.
76. Romagnani C, Juelke K, Falco M, et al. CD56brightCD16-killer Ig-like receptor-NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation. J Immunol 2007; 178:4947-4955.
77. Bell SP, Dutta A. DNA replication in eukaryotic cells. Annu Rev Biochem 2002; 71:333-374.
78. Bernard F, Picard C, Cormier-Daire V, et al. A novel developmental and immunodeficiency syndrome associated with intrauterine growth retardation and a lack of natural killer cells. Pediatrics 2004; 113 (1 Pt 1):136-141.
79. Matos ME, Schnier GS, Beecher MS, et al. Expression of a functional c-kit receptor on a subset of natural killer cells. J Exp Med 1993; 178:1079-1084.
80. Vossen MT, Biezeveld MH, de Jong MD, et al. Absence of circulating natural killer and primed CD8 ; cells in life-threatening varicella. J Infect Dis 2005; 191:198-206.
81. Kiessling R, Klein E, Wigzell H. Natural' killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur J Immunol 1975; 5:112-117.
82. Takasugi M, Mickey MR, Terasaki PI. Reactivity of lymphocytes from normal persons on cultured tumor cells. Cancer Res 1973; 33:2898-2902.
83. Jondal M, Pross H. Surface markers on human b and t lymphocytes. VI. Cytotoxicity against cell lines as a functional marker for lymphocyte subpopulations. Int J Cancer 1975; 15:596-605.
84. Alcais A, Quintana-Murci L, Thaler DS, et al. Life-threatening infectious diseases of childhood: single-gene inborn errors of immunity? Ann N Y Acad Sci 2010; 1214:18-33.
85. Casanova J, Abel L. The genetic theory of infectious diseases: brief history and selected illustrations. Annu Rev Genomics Hum Genet 2013; 14:215-243.
86. Casanova JL, Abel L. Primary immunodeficiencies: A field in its infancy. Science 2007; 317:617-619.
87. Quintana-Murci L, Alcais A, Abel L, Casanova JL. Immunology in nature: clinical, epidemiological and evolutionary genetics of infectious diseases. Nat Immunol 2007; 8:1165-1171.